Massive GIST registry aims to unlock secrets of rare cancer
NCT ID NCT07697248
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study is a patient registry for people diagnosed with gastrointestinal stromal tumor (GIST). It collects detailed information about participants' health, treatments, and outcomes over time. The goal is to help researchers better understand the disease, track how patients fare, and ultimately improve care for everyone with GIST.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help researchers better understand GIST, identify effective treatments, and improve patient care.
- What could go wrong
- This is an observational registry, not a treatment trial. It collects data but does not test any intervention, so direct benefits to participants are unlikely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL STROMAL TUMOR (GIST) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Life Raft Group
RECRUITINGWayne, New Jersey, 07470, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Metabolic MRI may reveal tumor response to GIST drug in weeks, not months
- Can a targeted pill shrink a rare, Treatment-Resistant stomach cancer?
- Blood test may guide cancer care without biopsy
- New Two-Tooth clip aims to make stomach tumor removal safer and faster
- New pill HQP1351 enters human testing for stubborn cancers
- New drug combo shows promise for Hard-to-Treat stomach cancer